Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Daily interferon therapy for hepatitis C virus infection in liver transplant recipients.

Transplantation - 27 Jan 2001

Cotler S J, Ganger D R, Kaur S, Rosenblate H, Jakate S, Sullivan D G, Ng K W, Gretch D R, Jensen D M

Abstract excerpt

BACKGROUND: Hepatitis C virus infection persists after liver transplantation and causes recurrent liver injury in the majority of patients. Standard dose interferon therapy has been largely unsuccessful for hepatitis C in transplant recipients. METHODS: Twelve patients, at least 7 months posttransplant, with detectable hepatitis C virus RNA in serum and features of hepatitis C on liver biopsy were randomized to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fatigue
Share to Hepacivirus
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Liver Transplantation

Share to Nausea

Source

Identifiers

PMID: 11213071
DOI: 10.1097/00007890-200101270-00017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Daily interferon therapy for hepatitis C virus infection in liver transplant recipients.PMID 11213071Read ↗

A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype.Semantic proximity Read ↗

Hepatitis C virus in the transplant setting.Semantic proximity Read ↗

A longitudinal analysis of hepatitis C virus replication following liver transplantation.Semantic proximity Read ↗

Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.Semantic proximity Read ↗

An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant.Semantic proximity Read ↗

Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection.Semantic proximity Read ↗

Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World Study.Semantic proximity Read ↗

Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study.Semantic proximity Read ↗

Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C.Semantic proximity Read ↗

Long-term outcome of hepatitis C infection after liver transplantation.Semantic proximity Read ↗

Daily interferon induction regimen using different manufactured interferons (alpha-2A or alpha-2B) in combination with ribavirin for treatment of chronic hepatitis C: a prospective randomized study.Semantic proximity Read ↗

Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.